Verition Fund Management’s GSK GSK Stock Holding History

Verition Fund Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-42,500	Closed	-$2.08M	–	2812
2025 Q4	$2.08M	Sell	42,500 -6,100	-13%	-$285K	0.01%	1579
2025 Q3	$2.1M	Sell	48,600 -2,300	-5%	-$89.8K	0.01%	1932
2025 Q2	$1.95M	Buy	50,900 +15,000	+42%	+$573K	0.01%	1967
2025 Q1	$1.39M	Buy	+35,900	New	+$1.31M	0.01%	1850
2024 Q4	–	Sell	-36,000	Closed	-$1.47M	–	3340
2024 Q3	$1.47M	Buy	36,000 +14,500	+67%	+$593K	0.01%	1615
2024 Q2	$828K	Hold	21,500	–	–	﹤0.01%	1791
2024 Q1	$922K	Buy	+21,500	New	+$887K	0.01%	1668
2023 Q1	–	Sell	-6,700	Closed	-$235K	–	2313
2022 Q4	$235K	Buy	+6,700	New	+$223K	﹤0.01%	1640
2022 Q2	–	Sell	-4,960	Closed	-$270K	–	2633
2022 Q1	$270K	Hold	4,960	–	–	﹤0.01%	2202
2021 Q4	$273K	Buy	+4,960	New	+$258K	﹤0.01%	2045

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Verition Fund Management's GSK Position: Q2 2026 in Review

Verition Fund Management held its GSK (GSK) position steady in Q2 2026 at 41,337 shares worth $2.17M. The position accounts for 0.01% of the portfolio, ranked #1056.

Verition Fund Management first reported a position in GSK in Q2 2013 and has held it in 21 quarters since. The position peaked at $23.4M in Q4 2019. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Verition Fund Management held 41,337 shares of GSK worth $2.17M as of Q2 2026.
Verition Fund Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1056 holding.
Verition Fund Management first reported a position in GSK in Q2 2013 and has held it in 21 quarters since.
Verition Fund Management's GSK position peaked at $23.4M in Q4 2019.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.